Intact mass analysis reveals the novel O-linked glycosylation on the stalk region of PD-1 protein

Tit‑oon P, Wonglangka A, Boonkanta K, Ruchirawat M,
Fuangthong M, Sasisekharan R, Khongmanee A

Sci Rep. 2023;13:9631.

Generation of bispecific antibodies by structure-guided redesign of IgG constant regions.

Iwasaki YW, Tharakaraman K, Subramanian V, Khongmanee A, Hatas A, Fleischer E, Rurak TT, Ngok-Ngam P, Tit-Oon P, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Front Immunol. 2023 Jan 10;13:1063002.

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.

Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Sci Rep. 2022 Aug 30;12(1):14754.

Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.

Suriyo T, Fuangthong M, Artpradit C, Ungtrakul T, Sricharunrat T, Taha F, Satayavivad J.

Eur J Pharmacol. 2021 Apr 15;897:173960.

Modified recombinant human erythropoietin with potentially reduced immunogenicity.

Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R.

Sci Rep. 2021 Jan 15;11(1):1491.